Related Experiment Videos
Apoptosis induced by a human milk protein
A Håkansson1, B Zhivotovsky, S Orrenius
1Department of Medical Microbiology, Lund University, Sweden.
Summary
Human milk contains multimeric alpha-lactalbumin, a molecule that induces cell death (apoptosis) in cancer cells but spares healthy ones. This discovery suggests milk aids mucosal immunity by targeting abnormal host cells.
Area of Science:
- Biochemistry
- Immunology
- Cell Biology
Background:
- Human milk provides nutrients and antimicrobial factors for infant immunity.
- The potential for milk components to affect host cells has been largely unexplored.
- While studying bacterial adherence, researchers observed milk's cytotoxic effect on cancer cells.
Purpose of the Study:
- To identify milk components with bioactivity towards host cells.
- To characterize the cytotoxic agent and its mechanism of action.
- To explore the implications for mucosal immunity and potential therapeutic applications.
Main Methods:
- Investigated human milk's effect on bacterial adherence to a lung cancer cell line.
- Analyzed milk components responsible for observed cytotoxicity.
- Assessed the Ca(2+)-elevating and apoptosis-inducing properties of identified components.
- Tested the selective cytotoxic activity against various cell types (transformed, embryonic, lymphoid, mature epithelial).
Main Results:
- A specific form of milk protein, multimeric alpha-lactalbumin, was identified as cytotoxic.
- Multimeric alpha-lactalbumin potently elevates intracellular calcium and induces apoptosis.
- This protein demonstrated selective cytotoxicity, killing transformed, embryonic, and lymphoid cells while sparing mature epithelial cells.
- The mechanism of apoptosis induction in transformed epithelial cells was analyzed.
Conclusions:
- Human milk contains multimeric alpha-lactalbumin, a potent inducer of apoptosis with selective cytotoxic activity.
- This finding suggests a novel role for milk in mucosal immunity through the elimination of abnormal host cells.
- Further research into multimeric alpha-lactalbumin's mechanism could lead to the development of new anticancer therapies.